Collis Steven H insider trades
Collis Steven H has filed 69 Form 4s with the SEC that we hold, for Cencora, Inc. (COR) (Executive Chairman, Director), Bausch & Lomb Corp (BLCO) (Director) and Elevance Health, Inc. (ELV) (Director). Across all of them we count 2 purchases worth $1.1M and 58 sales worth $178.9M reported on Form 4. In the last 12 months: 2 purchases ($1.1M) and 0 sales ($0). The largest single trade was a sale of 50,000 shares of Cencora, Inc. worth $12.2M, dated 2024-11-25. The first filing on our record is dated 2021-07-14 and the latest 2026-05-28.
Cencora, Inc. (COR)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-07-13 | S, sale reported on Form 4 | 20,912 | $2.4M | 2021-07-14 |
| 2021-07-20 | S, sale reported on Form 4 | 12,784 | $1.5M | 2021-07-21 |
| 2021-08-10 | S, sale reported on Form 4 | 20,912 | $2.5M | 2021-08-12 |
| 2021-08-17 | S, sale reported on Form 4 | 12,784 | $1.5M | 2021-08-19 |
| 2021-09-20 | S, sale reported on Form 4 | 24,265 | $3.0M | 2021-09-22 |
| 2021-10-12 | S, sale reported on Form 4 | 24,265 | $2.9M | 2021-10-14 |
| 2021-11-09 | S, sale reported on Form 4 | 24,264 | $3.0M | 2021-11-12 |
| 2021-11-16 | S, sale reported on Form 4 | 11,664 | $1.5M | 2021-11-18 |
| 2021-11-24 | S, sale reported on Form 4 | 17,168 | $2.1M | 2021-11-29 |
| 2021-12-14 | S, sale reported on Form 4 | 24,264 | $3.0M | 2021-12-15 |
| 2021-12-15 | S, sale reported on Form 4 | 17,168 | $2.1M | 2021-12-16 |
| 2022-01-11 | S, sale reported on Form 4 | 24,264 | $3.3M | 2022-01-13 |
| 2022-02-08 | S, sale reported on Form 4 | 24,263 | $3.4M | 2022-02-09 |
| 2022-03-08 | S, sale reported on Form 4 | 11,480 | $1.7M | 2022-03-09 |
| 2022-04-12 | S, sale reported on Form 4 | 11,480 | $1.9M | 2022-04-13 |
| 2022-05-10 | S, sale reported on Form 4 | 11,480 | $1.8M | 2022-05-12 |
| 2022-06-14 | S, sale reported on Form 4 | 11,480 | $1.6M | 2022-06-16 |
| 2022-07-12 | S, sale reported on Form 4 | 11,480 | $1.6M | 2022-07-14 |
| 2022-08-09 | S, sale reported on Form 4 | 11,480 | $1.7M | 2022-08-11 |
| 2022-09-13 | S, sale reported on Form 4 | 11,480 | $1.6M | 2022-09-15 |
| 2022-10-11 | S, sale reported on Form 4 | 11,480 | $1.6M | 2022-10-12 |
| 2022-12-12 | S, sale reported on Form 4 | 33,000 | $5.5M | 2022-12-14 |
| 2022-12-13 | S, sale reported on Form 4 | 38,218 | $6.3M | 2022-12-14 |
| 2022-12-13 | S, sale reported on Form 4 | 920 | $154.5K | 2022-12-14 |
| 2022-12-13 | S, sale reported on Form 4 | 6,782 | $1.1M | 2022-12-14 |
| 2023-01-17 | S, sale reported on Form 4 | 10,499 | $1.7M | 2023-01-19 |
| 2023-02-14 | S, sale reported on Form 4 | 10,499 | $1.7M | 2023-02-16 |
| 2023-03-14 | S, sale reported on Form 4 | 10,499 | $1.6M | 2023-03-15 |
| 2023-04-11 | S, sale reported on Form 4 | 10,499 | $1.8M | 2023-04-13 |
| 2023-05-09 | S, sale reported on Form 4 | 10,499 | $1.8M | 2023-05-10 |
| 2023-06-13 | S, sale reported on Form 4 | 10,499 | $1.9M | 2023-06-14 |
| 2023-07-11 | S, sale reported on Form 4 | 10,499 | $2.0M | 2023-07-12 |
| 2023-08-08 | S, sale reported on Form 4 | 10,499 | $2.0M | 2023-08-09 |
| 2023-09-12 | S, sale reported on Form 4 | 10,500 | $1.9M | 2023-09-13 |
| 2023-10-10 | S, sale reported on Form 4 | 25,000 | $4.6M | 2023-10-11 |
| 2023-11-14 | S, sale reported on Form 4 | 25,000 | $4.9M | 2023-11-15 |
| 2023-12-12 | S, sale reported on Form 4 | 25,000 | $5.1M | 2023-12-13 |
| 2023-12-13 | S, sale reported on Form 4 | 42,885 | $8.7M | 2023-12-15 |
| 2024-03-19 | S, sale reported on Form 4 | 10,755 | $2.6M | 2024-03-21 |
| 2024-04-16 | S, sale reported on Form 4 | 10,754 | $2.6M | 2024-04-17 |
| 2024-05-21 | S, sale reported on Form 4 | 10,755 | $2.4M | 2024-05-22 |
| 2024-06-18 | S, sale reported on Form 4 | 10,754 | $2.5M | 2024-06-20 |
| 2024-07-16 | S, sale reported on Form 4 | 10,755 | $2.4M | 2024-07-17 |
| 2024-08-20 | S, sale reported on Form 4 | 10,754 | $2.6M | 2024-08-21 |
| 2024-09-17 | S, sale reported on Form 4 | 21,509 | $5.2M | 2024-09-18 |
| 2024-10-22 | S, sale reported on Form 4 | 21,509 | $5.1M | 2024-10-23 |
| 2024-11-19 | S, sale reported on Form 4 | 21,509 | $5.2M | 2024-11-21 |
| 2024-11-25 | S, sale reported on Form 4 | 50,000 | $12.2M | 2024-11-26 |
| 2025-02-27 | S, sale reported on Form 4 | 2,000 | $502.2K | 2025-02-28 |
| 2025-02-27 | S, sale reported on Form 4 | 12,579 | $3.2M | 2025-02-28 |
| 2025-03-25 | S, sale reported on Form 4 | 2,000 | $539.0K | 2025-03-26 |
| 2025-03-25 | S, sale reported on Form 4 | 12,578 | $3.4M | 2025-03-26 |
| 2025-04-22 | S, sale reported on Form 4 | 14,579 | $4.1M | 2025-04-23 |
| 2025-05-20 | S, sale reported on Form 4 | 14,578 | $4.3M | 2025-05-21 |
| 2025-06-24 | S, sale reported on Form 4 | 14,579 | $4.3M | 2025-06-25 |
| 2025-07-22 | S, sale reported on Form 4 | 14,578 | $4.3M | 2025-07-23 |
| 2025-08-19 | S, sale reported on Form 4 | 14,579 | $4.2M | 2025-08-20 |
| 2025-09-16 | S, sale reported on Form 4 | 31,350 | $9.1M | 2025-09-18 |
Bausch & Lomb Corp (BLCO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-02-23 | P, purchase reported on Form 4 | 15,000 | $267.1K | 2026-02-24 |
Elevance Health, Inc. (ELV)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-03-05 | P, purchase reported on Form 4 | 3,000 | $869.5K | 2026-03-06 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1191508) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms